Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Colorcon
McKesson
Johnson and Johnson
Harvard Business School
Dow

Last Updated: January 23, 2020

DrugPatentWatch Database Preview

Claims for Patent: 7,037,513

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Summary for Patent: 7,037,513
Title:Bodywash additives
Abstract: The invention encompasses additives for addition to a composition for topical application, e.g., a bodywash, where the additive contains an encapsulated non-sunscreen, and methods of making and using the additives as well as topical compositions containing the additives. The additive may be encapsulated in a sol-gel microcapsule, and, in some cases, also includes a cationic polymer.
Inventor(s): Traynor; Daniel Henry (Sarasota, FL), Traynor; Henry G. (Sarasota, FL), Markowitz; Steven M. (Honolulu, HI), Compton; David L. (Ventura, CA)
Assignee: Aquea Scientific Corporation (Westlake Village, CA)
Application Number:11/076,089
Patent Claims:1. An additive for addition to a bodywash, wherein the additive comprises a non-sunscreen active that is encapsulated in a sol-gel microcapsule, a film former, and a cationic polymer.

2. The additive of claim 1 wherein the cationic polymer is a polyquatemium.

3. The additive of claim 2 wherein the polyquatemium is polyquaternium-4, -7, -11, -22, -27, -44, -51, or -64.

4. The additive of claim 3, wherein the cationic polymer is polyquatemium-4.

5. The additive of claim 1 wherein the film former comprises petrolatum.

6. The additive of claim 1 further comprising a preservative.

7. The additive of claim 1 further comprising an antioxidant that is stable upon exposure to sunlight.

8. The additive of claim 1 wherein the sol-gel microcapsule is silica or modified silica.

9. The additive of claim 1 comprising at least two non-sunscreen actives.

10. The additive of claim 1 wherein the non-sunscreen active is selected from the group consisting of steroidal anti-inflammatory actives, analgesic actives, antifungals, antibacterials, and antiparasitics, anti-allergenics, medicinal actives, skin rash, skin disease and dermatitis medications, insect repellant actives, antioxidants, hair growth promoter, hair growth inhibitor, hair bleaching agents, deodorant compounds, and mixtures and combinations thereof.

11. The additive of claim 1 wherein the active comprises an agent that is effective in counteracting the effects of chemical, radiological, or biological agents on the skin.

12. An additive for addition to a bodywash, wherein the additive comprises sol-gel microcapsules that do not contain any active ingredients, a film former, and a cationic polymer.

13. The additive of claim 12 wherein the sol-gel microcapsules provide a physical barrier to protect the skin.

14. A bodywash comprising an additive, wherein the additive comprises a non-sunscreen active encapsulated in a sol-gel microcapsule, a film former, and further comprises a cationic polymer.

15. The composition of claim 14 wherein the cationic polymer is a polyquaternium.

16. The composition of claim 15 wherein the polyquaternium is polyquaternium-4, -7, -11, -22, -27, -44, -51, or -64.

17. The composition of claim 16, wherein the cationic polymer is polyquaternium-4.

18. The composition of claim 14 wherein the film former comprises petrolatum.

19. The composition of claim 14 further comprising a preservative.

20. The composition of claim 14 further comprising an antioxidant that is stable upon exposure to sunlight.

21. The composition of claim 14 comprising at least two non-sunscreen actives.

22. The composition of claim 14 wherein the non-sunscreen active is selected from the group consisting of steroidal anti-inflammatory actives, analgesic actives, antifungals, antibacterials, and antiparasitics, anti-allergenics, medicinal actives, skin rash, skin disease and dermatitis medications, insect repellant actives, antioxidants, hair growth promoter, hair growth inhibitor, hair bleaching agents, deodorant compounds, and mixtures and combinations thereof.

23. The composition of claim 14 wherein the active comprises an agent that is effective in counteracting the effects of chemical, radiological, or biological agents on the skin.

24. The composition of claim 1 wherein the non-sunscreen active is a humectant selected from the group consisting of urea, guanidine, sorbitol, hexanetriol, propylene glycol, hexylene glycol, polyethylene glycol, sugars, starches, sugar derivatives, starch derivatives, D-panthenol, hyaluronic acid, lactamide monoethanolamine, acetamide monoethanolamine, and mixtures thereof.

25. The composition of claim 1 wherein the additive is an antiwrinkling agent selected from the group consisting of botox, octanoyl salicylate, mandelic acid, glyceric acid, N-acetyl-L-cysteine, lipoic acid, thiols, ethane thiol, ceramides, pseudoceramides, phospholipids, fatty acids, fatty alcohols, cholesterol, plant sterols, phytic acid, lysophosphatidic acid, phenol, and mixtures thereof.

Details for Patent 7,037,513

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Allergan BOTOX onabotulinumtoxina VIAL; SINGLE-USE 103000 001 1991-12-09   Start Trial Aquea Scientific Corporation (Westlake Village, CA) 2025-01-31 RX search
Allergan BOTOX onabotulinumtoxina VIAL; SINGLE-USE 103000 002 1991-12-09   Start Trial Aquea Scientific Corporation (Westlake Village, CA) 2025-01-31 RX search
Allergan BOTOX onabotulinumtoxina VIAL; SINGLE-USE 103000 003 1991-12-09   Start Trial Aquea Scientific Corporation (Westlake Village, CA) 2025-01-31 RX search
Allergan BOTOX COSMETIC onabotulinumtoxina VIAL; SINGLE-USE 103000 004 1991-12-09   Start Trial Aquea Scientific Corporation (Westlake Village, CA) 2025-01-31 RX search
Allergan BOTOX COSMETIC onabotulinumtoxina VIAL; SINGLE-USE 103000 005 1991-12-09   Start Trial Aquea Scientific Corporation (Westlake Village, CA) 2025-01-31 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

International Patent Family for US Patent 7,037,513

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Colorcon
Baxter
Mallinckrodt
Express Scripts
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.